苏州明志科技股份有限公司于近日发布2024年年度报告，报告期内公司多项财务数据出现较大变化。其 中，净利润同比增长352.42%，而经营活动产生的现金流量净额同比下降38.56%。这两项数据的巨大反 差，值得投资者密切关注。 营业收入稳健增长，业务结构优化成效显著 2024年，明志科技实现营业收入631,484,178.63元，同比增长18.37%。从业务板块来看，装备产品实现 销售22,531.01万元，同比增长33.60%；铸件产品实现销售37,332.84万元，同比增长9.51%。装备项目本 年度验收交付情况较好，成为带动销售收入增长的主要动力。公司积极拓展新的产品应用领域和市场， 在装备业务领域开拓了意大利、英国等欧洲新客户，铸件业务领域拓展进入工程机械的阀体类零件开发 并进行了批量生产，还布局了新能源行业的新兴产品。这些举措不仅推动了营业收入的增长，也优化了 公司的业务结构，提升了公司的市场竞争力。 净利润大幅增长，盈利能力显著提升 归属于上市公司股东的净利润为66,340,005.18元，同比增长352.42%；归属于上市公司股东的扣除非经 常性损益的净利润为34,397,940.13元，上年同期 ...

4月29日，荣盛石化（002493.SZ）发布了其2025年第一季度报告，展现了公司在复杂市场环境下依旧保 持的强劲经营现金流表现。尤其引人注目的是，公司经营活动产生的现金流量净额达到了79.77亿元， 同比大幅增长了93.19%，显示出荣盛石化在面对行业挑战时所展现出的坚韧与活力。 回顾过去一年，即2024年，荣盛石化实现了经营活动产生的现金净流量达到346.09亿元的历史新高，同 比增长23.26%。而更令人瞩目的是，在过去的五年间，公司累计经营活动现金净流入超过了1300亿 元，这不仅体现了荣盛石化的稳健经营风格，也标志着其经营质量的显著提升。强大的现金流为公司的 可持续发展奠定了坚实的基础，同时也赋予了公司进行持续分红、股份回购及增持等回馈股东行为的底 气。 荣盛石化始终将投资者利益保护作为其核心战略之一，坚持通过持续稳健的分红政策和实际有力的资本 回馈来实现"与股东共成长"的承诺。自上市以来，公司已连续15次年现金分红，近三年内现金分红占归 母净利润的比例高达64.93%。特别是2024年度，荣盛石化计划向全体股东每10股派发现金红利1.00元 （含税），总计拟分配现金红利达9.57亿元。此外，全年 ...

首批追踪中证全指自由现金流指数的ETF可以场内交易了！基金公告显示，2025年4月30日，华泰柏瑞 中证全指自由现金流ETF（简称"现金流ETF全指"，代码563390）正式登录上交所，通过聚焦100家自由 现金流率较高的企业，较为全面的刻画A股现金流创造能力较强上市公司的整体表现，为投资者一键参 与自由现金流策略再添多元配置方案。 面对当前"不确定性"为主旋律的投资环境，能够较为稳定产生自由现金流的优质资产正凭借其在经营成 本、营运效率等方面的独特优势，在震荡市场中逐渐展现出了较强韧性，配置吸引力日渐升温。因此， 以"自由现金流率"为核心选股指标的中证全指自由现金流指数一经发布便备受关注，截至最新，已成为 吸引最多公募基金管理人扎堆布局的人气品种。（数据截至2025/4/28） 据悉，本次上市的现金流ETF全指（563390）将通过完全复制法紧密追踪中证全指自由现金流指数，从 指数的编制规则来看，亮点主要有二。 一是在全部A股范畴内选股，并且最终入选的成份股数量为100家。更广阔的样本空间与更多的成份股 数量，不仅更有助于分散个股风险，也能提升标的指数对A股整体高现金流率资产的代表性。 二是从选股指标来看， ...

近期晶华新材(603683)发布2025年一季报，证券之星财报模型分析如下： 营收与利润 晶华新材(603683)在2025年一季度实现了4.38亿元的营业总收入，同比增长了12.67%。然而，归母净利 润却出现了下滑，从2024年同期的2157.97万元下降至1879.07万元，降幅为12.92%。扣非净利润也从 2105.05万元降至1858.2万元，同比减少了11.73%。 晶华新材的业绩主要依赖于研发、股权融资及资本开支驱动。公司自上市以来累计融资总额为7.32亿 元，累计分红总额为7094.29万元，分红融资比为0.1。需要注意的是，资本开支项目的合理性以及是否 存在资金压力是投资者应重点关注的问题。 总结 总体来看，晶华新材在2025年一季度虽然实现了营收的增长，但利润出现下滑，且应收账款、现金流和 债务状况均存在一定风险，需持续关注这些方面的变化。 债务状况 有息负债从2024年一季度的5.96亿元增加到2025年一季度的7.57亿元，同比增长了26.92%，有息资产负 债率达到了26.78%，需关注公司的债务偿还能力。 主要财务指标 商业模式与资本运作 毛利率：2025年一季度毛利率为16.8 ...

Core Viewpoint - Gotion High-Tech (688390) reported a significant increase in revenue for Q1 2025, with total operating income reaching 1.882 billion yuan, a year-on-year increase of 67.13%, while the net profit attributable to shareholders narrowed to -28.03 million yuan, reflecting a 2.75% improvement year-on-year [1] Financial Performance - Total operating revenue for Q1 2025 was 1.882 billion yuan, up 67.13% from 1.126 billion yuan in Q1 2024 [1] - The net profit attributable to shareholders for Q1 2025 was -28.03 million yuan, compared to -28.82 million yuan in Q1 2024, showing a 2.75% improvement [1] - Gross margin decreased to 19.41%, down 29.33% year-on-year, while net margin improved to -0.57%, a 66.62% increase year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 221 million yuan, accounting for 11.72% of revenue, a decrease of 31.57% year-on-year [1] - Earnings per share remained at -0.12 yuan, with operating cash flow per share improving to -1.04 yuan, a 74.68% increase year-on-year [1] Balance Sheet Highlights - Cash and cash equivalents increased to 1.112 billion yuan, a 22.58% rise from 907 million yuan [1] - Accounts receivable rose significantly to 1.117 billion yuan, up 75.19% from 637 million yuan [1] - Interest-bearing debt surged to 1.5 billion yuan, a substantial increase of 240.29% from 441 million yuan [1] - Net asset value per share decreased to 11.25 yuan, down 34.40% year-on-year from 17.15 yuan [1] Market Position and Investor Sentiment - The company has a low return on invested capital (ROIC) of 0.72%, indicating weak capital returns in recent years [1] - Analysts project a revenue of 324 million yuan for 2025, with an average earnings per share estimate of 1.33 yuan [2] - Several funds have increased their holdings in Gotion High-Tech, with HSBC Jintrust Low Carbon Pioneer Stock A being the largest holder, managing 3.853 billion yuan [3]

Core Insights - The company reported a mixed performance in revenue, profit, and cash flow for 2024, with significant changes in various financial metrics [1] Revenue - The company achieved a revenue of 4,695,947,539.30 CNY, a slight increase of 0.87% from the previous year [2] - The core revenue source is the casting business, contributing 462,075.48 million CNY, with a notable decline in ductile iron product revenue by 5.30% [2] - Domestic sales decreased by 0.98% to 388,394.93 million CNY, while international sales increased by 5.86% to 73,680.55 million CNY [2] Profit - Net profit attributable to shareholders rose by 29.55% to 623,809,070.27 CNY, largely due to non-recurring gains from the disposal of subsidiary equity [3] - Excluding non-recurring items, the net profit fell by 21.57% to 333,258,314.06 CNY, indicating underlying profit pressure from declining sales prices [3] Earnings Per Share - Basic earnings per share increased by 29.79% to 0.61 CNY, while the adjusted earnings per share decreased by 19.51% to 0.33 CNY, reflecting reliance on non-recurring gains [4] Expenses - Sales expenses significantly decreased by 59.18% to 16,255,033.77 CNY, attributed to a change in cost allocation [5] - Management expenses grew by 6.82% to 188,298,893.08 CNY, driven by increased asset depreciation and amortization [6] - Financial expenses decreased by 44.47% to -57,596,479.28 CNY, influenced by reduced foreign exchange gains and interest income [7] - R&D expenses fell by 12.09% to 227,436,636.07 CNY, raising concerns about future innovation capabilities [8] Cash Flow - Operating cash flow net amount decreased by 125.67% to -158,231,624.33 CNY, indicating potential liquidity issues [11] - Investment cash flow net amount increased significantly to 824,217,577.85 CNY, reflecting improved capital recovery [12] - Financing cash flow net amount decreased by 18.69% to 357,688,613.48 CNY, suggesting a cautious approach to funding [13] R&D and Personnel - The company maintains a stable R&D personnel structure with 308 employees, focusing on continuous technological innovation despite reduced R&D spending [10] Risks - The company faces risks related to raw material price fluctuations, market demand volatility, and potential operational challenges due to its significant fixed asset investments [14]

证券之星价投圈财报分析工具显示：业务评价：公司去年的ROIC为6.38%，资本回报率一般。去年的净 利率为4.84%，算上全部成本后，公司产品或服务的附加值不高。融资分红：公司上市2年以来，累计 融资总额60.06亿元，累计分红总额4.43亿元，分红融资比为0.07。商业模式：公司业绩主要依靠资本开 支驱动，还需重点关注公司资本开支项目是否划算以及资本支出是否刚性面临资金压力。需要仔细研究 这类驱动力背后的实际情况。 财报体检工具显示：建议关注公司现金流状况(货币资金/流动负债仅为50.24%)建议关注公司债务状况 (有息资产负债率已达25.55%)建议关注公司应收账款状况(应收账款/利润已达327.9%) 据证券之星公开数据整理，近期阿特斯(688472)发布2025年一季报。截至本报告期末，公司营业总收入 85.86亿元，同比下降10.54%，归母净利润4725.82万元，同比下降91.83%。按单季度数据看，第一季度 营业总收入85.86亿元，同比下降10.54%，第一季度归母净利润4725.82万元，同比下降91.83%。本报告 期阿特斯应收账款上升，应收账款同比增幅达33.18%。 本次财报公布的各 ...

Revenue and Profitability - The company reported a revenue of 3.825 billion yuan in 2024, a decrease of 10.26% compared to 4.263 billion yuan in 2023, indicating significant market pressure due to industry policy changes and intensified competition [1] - The net profit attributable to shareholders was 33.62 million yuan, a substantial increase of 108.11% from a loss of 415 million yuan in 2023, primarily driven by non-recurring gains [2] - Basic earnings per share improved to 0.02 yuan, a 106.67% increase from -0.3 yuan in 2023, although the adjusted earnings per share remained negative at -0.06 yuan, highlighting the need for improved core business profitability [3] Cost Management and R&D Investment - Total expenses decreased to 2.1649 billion yuan, down 19.5% from 2.6891 billion yuan in 2023, reflecting effective cost control measures [4] - Sales expenses dropped significantly by 19.77%, while R&D expenses fell by 45.06%, raising concerns about the sustainability of innovation and future product development [5][6] - R&D investment was 60.9883 million yuan, accounting for 1.59% of revenue, a decrease from 1.95% in 2023, indicating a potential risk to future innovation capabilities [6] Cash Flow and Financial Health - Operating cash flow net amount was 9.0206 million yuan, a sharp decline of 92.83% from 126 million yuan in 2023, suggesting increased cash payment pressures [8] - Investment cash flow net amount increased to 80.5186 million yuan from a negative 34.8313 million yuan in 2023, indicating a positive shift in investment strategy [9] - Financing cash flow net amount improved to -169 million yuan, a 21.31% increase from -215 million yuan in 2023, reflecting reduced debt repayment pressures [10] Industry Challenges and Management Actions - The pharmaceutical industry faces intensified regulatory scrutiny and competitive pressures, necessitating strategic adjustments to maintain market position [11][12] - The chairman voluntarily forwent salary to demonstrate commitment to cost control, enhancing trust between management and shareholders [14] - Other executives' salaries remained stable, but the effectiveness of the compensation structure in driving long-term performance needs further evaluation [15]

证券代码：000498 证券简称：山东路桥 山东高速路桥集团股份有限公司投资者关系活动记录表 编号：2025-4 | 投资者关系活 | □特定对象调研 □分析师会议 | | --- | --- | | 动类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | 其他（电话会议） | | 活动参与人员 | 中泰证券股份有限公司侯希得及 6 家机构投资者 | | | 山东路桥证券管理部部长、证券事务代表李文佳 | | | 山东路桥经营开发部专员张堃 | | | 山东路桥证券管理部投资者关系管理专员朱晓赛 | | 时间 | 2025 年 4 月 29 日 10:00-10:40 | | 地点 | 山东高速路桥集团股份有限公司 25 楼 | | 形式 | 电话会议 | | 交流内容及具 | 一、介绍公司情况 | | | 二、互动交流 | | | 1.公司现金流是否会进一步改善？ | | | 2025 年一季度，公司通过加强现金流管理，经营 | | | 活动产生的现金流量净额同比增长 81.03%，净现金流 | | | 有所改善。 | | | 2.公司目前订单的整体 ...

2025 年 04 月 29 日 与传统风格相关性更低，A 股资产配置 新方向：大成中证全指自由现金流 ETF （159235）投资价值分析 ——指数基金产品研究系列报告之二百四十七 本研究报告仅通过邮件提供给 中庚基金 使用。1 证 券 研 究 报 告 施佳瑜 A0230521040004 shijy@swsresearch.com 研究支持 方思齐 A0230123090003 fangsq@swsresearch.com 联系人 方思齐 (8621)23297818× fangsq@swsresearch.com 益 量 化 研 究 权 请务必仔细阅读正文之后的各项信息披露与声明 第2页 共25页 简单金融 成就梦想 股 票 基 金 证券分析师 邓虎 A0230520070003 denghu@swsresearch.com 请务必仔细阅读正文之后的各项信息披露与声明 ⚫ 现金流 ETF 已经成为海外市场热门产品，国内产品申报火热。国内自由现金流产品目前 处于起步阶段，而海外现金流产品已经取得了丰硕的发展成果。其中规模领先的 COWZ 规模已超 200 亿美元。近期国内现金流 ETF 迎来集中申报浪潮， ...